SRGN and non-small cell lung carcinoma: Correspondingly, increased serglycin expression was shown to facilitate liver colonization by cancer cells in a patient-derived xenograft model of non-small-cell lung cancer (NSCLC) (Guo et al., 2017) as well as to promote hepatocellular carcinoma metastasis to the bone (He et al., 2014).